Relmada Therapeutics Announces Collaboration With the Malvern Consulting …
Relmada Therapeutics Announces Collaboration With The Malvern Consulting …
NMDA antagonists have been shown to provide relief patients with neuropathic pain and to reduce analgesic tolerance to opioids. An open-label Phase I/IIa study at the Memorial Sloan Kettering Cancer Center showed that d-methadone was safe and well …
Read more on The Herald | HeraldOnline.com
Walgreens' "Secret Checklist" Reveals Controversial New Policy On Pain Pills
Oxycodone, Methadone, Hydromorphone (Dilaudid), Morphine, Fentanyl and Opana are included on the list of Walgreens' "target drugs" because they are all highly-addictive controlled substances that government regulators have placed in a high-risk …
Read more on WBIW.com
Relmada Therapeutics Announces Positive Results of LevoCap ER Pivotal …
This includes the vast category of patients affected by chronic pain with combined nociceptive and neuropathic components, which frequently require treatment with two or more pain medications to achieve efficacy. About Relmada … Relmada's strategy …
Read more on PR Newswire (press release)